• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度疫苗与疫苗接种简史。

A brief history of vaccines & vaccination in India.

作者信息

Lahariya Chandrakant

机构信息

Formerly Department of Community Medicine, G.R. Medical College, Gwalior, India.

出版信息

Indian J Med Res. 2014 Apr;139(4):491-511.

PMID:24927336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4078488/
Abstract

The challenges faced in delivering lifesaving vaccines to the targeted beneficiaries need to be addressed from the existing knowledge and learning from the past. This review documents the history of vaccines and vaccination in India with an objective to derive lessons for policy direction to expand the benefits of vaccination in the country. A brief historical perspective on smallpox disease and preventive efforts since antiquity is followed by an overview of 19 th century efforts to replace variolation by vaccination, setting up of a few vaccine institutes, cholera vaccine trial and the discovery of plague vaccine. The early twentieth century witnessed the challenges in expansion of smallpox vaccination, typhoid vaccine trial in Indian army personnel, and setting up of vaccine institutes in almost each of the then Indian States. In the post-independence period, the BCG vaccine laboratory and other national institutes were established; a number of private vaccine manufacturers came up, besides the continuation of smallpox eradication effort till the country became smallpox free in 1977. The Expanded Programme of Immunization (EPI) (1978) and then Universal Immunization Programme (UIP) (1985) were launched in India. The intervening events since UIP till India being declared non-endemic for poliomyelitis in 2012 have been described. Though the preventive efforts from diseases were practiced in India, the reluctance, opposition and a slow acceptance of vaccination have been the characteristic of vaccination history in the country. The operational challenges keep the coverage inequitable in the country. The lessons from the past events have been analysed and interpreted to guide immunization efforts.

摘要

要将拯救生命的疫苗提供给目标受益人群,就需要从现有知识以及过去的经验教训中去应对所面临的挑战。本综述记录了印度疫苗和疫苗接种的历史,目的是汲取经验教训,为扩大该国疫苗接种益处的政策方向提供指导。首先简要介绍了自古至今天花疾病及预防措施的历史概况,接着概述了19世纪用疫苗接种取代人痘接种的努力、一些疫苗机构的设立、霍乱疫苗试验以及鼠疫疫苗的发现。20世纪初见证了天花疫苗接种推广过程中面临的挑战、在印度军队人员中进行的伤寒疫苗试验,以及当时几乎每个印度邦都设立了疫苗机构。在独立后时期,建立了卡介苗疫苗实验室和其他国家机构;除了持续开展天花根除工作直至1977年该国消灭天花外,还出现了许多私营疫苗制造商。印度启动了扩大免疫规划(EPI)(1978年),随后又启动了全民免疫规划(UIP)(1985年)。文中描述了自全民免疫规划实施至2012年印度宣布脊髓灰质炎为非地方性疾病期间的相关事件。尽管印度一直在开展疾病预防工作,但民众对接种疫苗的不情愿、反对以及缓慢接受一直是该国疫苗接种历史的特点。这些操作上的挑战导致该国疫苗接种覆盖率不均衡。对过去事件的经验教训进行了分析和解读,以指导免疫工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d072/4078488/05c1132f28a8/IJMR-139-491-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d072/4078488/8c0a4e911dd8/IJMR-139-491-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d072/4078488/78516f921503/IJMR-139-491-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d072/4078488/05c1132f28a8/IJMR-139-491-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d072/4078488/8c0a4e911dd8/IJMR-139-491-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d072/4078488/78516f921503/IJMR-139-491-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d072/4078488/05c1132f28a8/IJMR-139-491-g010.jpg

相似文献

1
A brief history of vaccines & vaccination in India.印度疫苗与疫苗接种简史。
Indian J Med Res. 2014 Apr;139(4):491-511.
2
A brief history of vaccines: smallpox to the present.疫苗简史:从天花到现代
S D Med. 2013;Spec no:33-7.
3
Highlights of historical events leading to national surveillance of vaccination coverage in the United States.美国国家疫苗接种覆盖率监测相关历史事件要点。
Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):3-12. doi: 10.1177/00333549111260S202.
4
The History of the Personal Belief Exemption.个人信仰豁免的历史。
Pediatrics. 2020 Apr;145(4). doi: 10.1542/peds.2019-2551. Epub 2020 Mar 17.
5
Historical Lessons on Vaccine Hesitancy: Smallpox, Polio, and Measles, and Implications for COVID-19.疫苗犹豫的历史教训:天花、脊髓灰质炎和麻疹,以及对 COVID-19 的启示。
Perspect Biol Med. 2023;66(1):145-159. doi: 10.1353/pbm.2023.0008.
6
Another vaccine, another story: BCG vaccination against tuberculosis in India, 1948 to 1960.另一种疫苗,另一段故事:1948年至1960年印度卡介苗接种预防结核病情况
Cien Saude Colet. 2011 Feb;16(2):397-407. doi: 10.1590/s1413-81232011000200004.
7
Smallpox and polio eradication in India: comparative histories and lessons for contemporary policy.印度天花和脊髓灰质炎的根除:比较历史及对当代政策的启示
Cien Saude Colet. 2011 Feb;16(2):433-44. doi: 10.1590/s1413-81232011000200007.
8
A tale of two global health programs. Smallpox eradication's lessons for the antipolio campaign in India.两个全球卫生项目的故事。天花根除对印度消灭脊髓灰质炎运动的启示。
Am J Public Health. 2009 Jul;99(7):1176-84. doi: 10.2105/AJPH.2008.135624.
9
Smallpox Vaccine and Resident Responses in Modern Shanghai: Focusing on Regional and Cultural Comparison.天花疫苗与近代上海居民的反应:关注地域和文化的比较。
Uisahak. 2020 Apr;29(1):121-164. doi: 10.13081/kjmh.2020.29.121.
10
Prospects for the eradication of infectious diseases.根除传染病的前景。
Rev Infect Dis. 1984 May-Jun;6(3):405-11. doi: 10.1093/clinids/6.3.405.

引用本文的文献

1
Consensus to Conquer Challenges in Influenza Immunization in Pulmonology Practice in India: Proceedings of the Congregation on Influenza Vaccination in Chronic Lung Diseases (CIRCLE) Expert Committee Meet.印度肺部疾病实践中流感免疫接种挑战应对共识:慢性肺部疾病流感疫苗接种会议(CIRCLE)专家委员会会议纪要
Cureus. 2025 Jul 31;17(7):e89176. doi: 10.7759/cureus.89176. eCollection 2025 Jul.
2
Vaccine-Preventable Diseases in Pediatric Age Group in India: Recent Resurgence, Implications and Solutions.印度儿童年龄组中可通过疫苗预防的疾病:近期的再度流行、影响及解决方案
Indian J Pediatr. 2025 Apr 25. doi: 10.1007/s12098-025-05531-9.
3

本文引用的文献

1
Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial.单价人-牛(116E)轮状病毒疫苗在印度婴儿中的效力:一项随机、双盲、安慰剂对照试验。
Lancet. 2014 Jun 21;383(9935):2136-43. doi: 10.1016/S0140-6736(13)62630-6. Epub 2014 Mar 12.
2
Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development.团队科学与印度新型轮状病毒疫苗的研制:疫苗开发新框架
Lancet. 2014 Jun 21;383(9935):2180-3. doi: 10.1016/S0140-6736(14)60191-4. Epub 2014 Mar 12.
3
Adverse event following immunization (AEFI) surveillance in India, position paper of Indian Academy of Pediatrics,2013.
Seroprevalence of measles antibodies in women born between 1985 and 1999 in metropolitan city in India: a cross-sectional study.
印度大城市1985年至1999年出生女性中麻疹抗体的血清流行率:一项横断面研究。
BMJ Public Health. 2024 Dec 11;2(2):e001417. doi: 10.1136/bmjph-2024-001417. eCollection 2024 Dec.
4
Seropositive Rubella and Toxoplasmosis Among Females Attending Saudi Hospital.沙特医院就诊女性中的风疹和弓形虫血清阳性情况
J Trop Med. 2025 Feb 13;2025:4201991. doi: 10.1155/jotm/4201991. eCollection 2025.
5
Spatial targeting and integration across vaccination, vitamin A and deworming programs throughout India 2019-21.2019 - 21年印度全国疫苗接种、维生素A补充及驱虫计划的空间定位与整合
Int J Epidemiol. 2024 Oct 13;53(6). doi: 10.1093/ije/dyae160.
6
Trend of immunization & gap in vaccine doses as observed in National Family Health Survey rounds in India.在印度全国家庭健康调查各轮次中观察到的免疫接种趋势及疫苗接种剂量差距。
Indian J Med Res. 2024;160(3&4):303-311. doi: 10.25259/ijmr_1770_23.
7
Typhoid conjugate vaccine implementation in India: A review of supportive evidence.印度伤寒结合疫苗的实施:支持性证据综述
Vaccine X. 2024 Oct 1;21:100568. doi: 10.1016/j.jvacx.2024.100568. eCollection 2024 Dec.
8
Healthcare workers' perceptions and acceptance for COVID-19 vaccine for their children aged <18 years from the Region of Eastern Uttar Pradesh, India.印度北方邦东部地区医护人员对其18岁以下子女接种新冠疫苗的认知与接受情况。
J Family Med Prim Care. 2024 Sep;13(9):3709-3718. doi: 10.4103/jfmpc.jfmpc_1727_23. Epub 2024 Sep 11.
9
Vaccines coverage and associated factors among children aged 12-23 months in the Pawie district, Ethiopia: A cross-sectional study.埃塞俄比亚帕维区12至23个月大儿童的疫苗接种覆盖率及相关因素:一项横断面研究。
J Virus Erad. 2024 Sep 24;10(3):100391. doi: 10.1016/j.jve.2024.100391. eCollection 2024 Sep.
10
Developments and Trends of Immunization in India: A Narrative Review.印度免疫接种的发展与趋势:叙述性综述
Cureus. 2024 Aug 9;16(8):e66547. doi: 10.7759/cureus.66547. eCollection 2024 Aug.
预防接种后不良反应(AEFI)监测在印度,印度儿科学会的立场文件,2013 年。
Indian Pediatr. 2013 Aug;50(8):739-41. doi: 10.1007/s13312-013-0210-1.
4
Assessment of BCG vaccination in India. Third Report. 1960.印度卡介苗接种评估。第三次报告。1960年。
Indian J Med Res. 2013 Mar;137(3):571.
5
An assessment of hepatitis B vaccine introduction in India: Lessons for roll out and scale up of new vaccines in immunization programs.印度乙型肝炎疫苗引入评估:免疫规划中新疫苗推出和扩大规模的经验教训。
Indian J Public Health. 2013 Jan-Mar;57(1):8-14. doi: 10.4103/0019-557X.111357.
6
Introduction of Haemophilus influenzae type b (Hib) as pentavalent(DPT-HepB-Hib) vaccine in two states of India.在印度两个邦引入b型流感嗜血杆菌(Hib)五价疫苗(白百破-乙肝-Hib)。
Indian Pediatr. 2012 Sep;49(9):707-9. doi: 10.1007/s13312-012-0151-0.
7
Pandemic influenza A (H1N1) 2009 vaccine: an update.2009年甲型H1N1大流行性流感疫苗:最新情况
Indian J Med Microbiol. 2011 Jan-Mar;29(1):13-8. doi: 10.4103/0255-0857.76517.
8
India's National Technical Advisory Group on Immunisation.印度国家免疫技术咨询小组。
Vaccine. 2010 Apr 19;28 Suppl 1:A88-90. doi: 10.1016/j.vaccine.2010.02.041.
9
The Statistics of Anti-typhoid and Anti-cholera Inoculations, and the Interpretation of such Statistics in general.伤寒和霍乱接种统计,以及此类统计的一般解读
Proc R Soc Med. 1915;8(Sect Epidemiol State Med):113-94.
10
Vikings against tuberculosis: the International Tuberculosis Campaign in India, 1948-1951.抗击结核病的北欧海盗:1948 - 1951年印度国际结核病防治运动
Bull Hist Med. 2007 Summer;81(2):407-30. doi: 10.1353/bhm.2007.0022.